A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer
Clinical trial NCT06532032 · COMPLETED
Trial details
- NCT number
- NCT06532032
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-23
- Primary completion
- 2026-05-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.